Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World

Jae Pak Yi1,2, Chang Ik Yoon3, Su Hyun Lim1

  • 1Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea.

PubMed

Insights

The COVID-19 pandemic negatively impacted breast cancer recurrence-free survival, particularly in younger patients. Continued emphasis on timely cancer screening is vital for all age groups.

Area of Science:

  • Oncology
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic disrupted global healthcare, causing delays in cancer care.
  • South Korea's lockdown led to postponed breast cancer diagnoses and treatments.
  • Addressing the resulting treatment gap is crucial.

Purpose of the Study:

  • To evaluate the impact of the COVID-19 pandemic on breast cancer outcomes in South Korea.
  • To compare recurrence-free survival (RFS) and overall survival (OS) between pre-pandemic and pandemic periods.

Main Methods:

  • Retrospective cohort study of 716 breast cancer patients from five South Korean academic hospitals.
  • Comparison of patients diagnosed during May-July 2019 (pre-COVID) and May-July 2020 (COVID).
  • Primary endpoint: 3-year RFS. Secondary endpoints: 3-year OS, stage distribution, and age subgroups.

Main Results:

  • 3-year RFS was significantly lower in the COVID group (88.3%) compared to the pre-COVID group (89.7%).
  • 3-year OS was similar between groups (96.2% vs. 95.5%).
  • Younger patients (<65 years) showed a significant RFS difference, unlike older patients. Stage distribution remained comparable.

Conclusions:

  • The COVID-19 pandemic adversely affected 3-year RFS in breast cancer patients, especially younger ones.
  • No significant increase in advanced-stage disease was observed during the pandemic.
  • Maintaining timely cancer screening is essential, particularly for younger populations.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170